循环RNA在瘤微环境和免疫治疗中的作用
1Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
International journal of biological macromolecules
|June 1, 2023
概括
循环RNAs (circRNAs) 在癌症中至关重要,但它们在瘤微环境和癌症免疫治疗中的特定作用尚未完全理解. 本综述探讨了这些领域的circRNA功能,以推进癌症治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 癌症免疫疗法已经成为一种关键的治疗策略,在各种瘤类型中具有显著的疗效.
- 长非编码RNAs (lncRNAs) 和microRNAs (miRNAs) 是癌症免疫治疗的公认调节者.
- 循环RNAs (circRNAs) 涉及许多疾病,特别是癌症,具有既定的功能,但它们在瘤微环境和免疫治疗中的作用仍未得到充分研究.
研究的目的:
- 综合审查目前对瘤微环境中的循环RNA功能的理解.
- 阐明circRNAs在调节癌症免疫治疗反应中的特定作用.
- 突出circRNAs作为癌症免疫治疗中的治疗标或生物标记物的潜力.
主要方法:
- 关于circRNAs,瘤微环境和癌症免疫疗法的现有研究的文献综述.
- 在各种癌症模型中研究circRNA表达和功能的研究分析.
- 综合发现,将circRNA机制与免疫治疗结果联系起来.
主要成果:
- 循环RNAs参与调节瘤微环境中的免疫细胞功能和细胞因子生产.
- 已经证明特定的circRNAs会影响不同癌症免疫治疗方法的疗效.
- 不调节的circRNA表达与瘤进展和免疫逃避有关.
结论:
- 循环RNAs代表了瘤微环境的重要,但尚未完全理解的组成部分.
- 对circRNAs的进一步研究对于开发新且有效的癌症免疫治疗策略至关重要.
- 向circRNAs可能为增强患者对癌症免疫疗法的反应提供新的途径.
相关概念视频
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:27Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K